Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David R Matthews

Showing results (81-90 of 115) with videos related to

Pageof 12
Sort By:
Diabetes/Metabolism Research and Reviews|September 24, 2004
Severe hypoglycaemia in 1076 adult patients with type 1 diabetes: influence of risk markers and selectionUlrik Pedersen-Bjergaard, Stig Pramming, Simon R Heller, et al.
Diabetologia|January 14, 2015
Management of hyperglycaemia in type 2 diabetes, 2015: a patient-centred approach. Update to a position statement of the American Diabetes Association and the European Association for the Study of DiabetesSilvio E Inzucchi, Richard M Bergenstal, John B Buse, et al.
Diabetes Care|April 21, 2012
Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)Silvio E Inzucchi, Richard M Bergenstal, John B Buse, et al.
Circulation|March 19, 2019
Effects of Canagliflozin on Heart Failure Outcomes Associated With Preserved and Reduced Ejection Fraction in Type 2 Diabetes MellitusGemma A Figtree, Karin Rådholm, Terrance D Barrett, et al.
Diabetes Care|December 25, 2014
Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American Diabetes Association and the European Association for the Study of DiabetesSilvio E Inzucchi, Richard M Bergenstal, John B Buse, et al.
Plos One|April 16, 2015
Successful up-scaled population interventions to reduce risk factors for non-communicable disease in adults: results from the International Community Interventions for Health (CIH) Project in China, India and MexicoPamela A Dyson, Denis Anthony, Brenda Fenton, et al.
The Lancet. Diabetes & Endocrinology|June 26, 2018
Canagliflozin and renal outcomes in type 2 diabetes: results from the CANVAS Program randomised clinical trialsVlado Perkovic, Dick de Zeeuw, Kenneth W Mahaffey, et al.
Circulation|November 15, 2017
Canagliflozin for Primary and Secondary Prevention of Cardiovascular Events: Results From the CANVAS Program (Canagliflozin Cardiovascular Assessment Study)Kenneth W Mahaffey, Bruce Neal, Vlado Perkovic, et al.
Diabetes, Obesity & Metabolism|August 17, 2021
Reasons for hospitalizations in patients with type 2 diabetes in the CANVAS programme: A secondary analysisKent Y Feng, JingWei Li, Juliana Ianus, et al.
Diabetes, Obesity & Metabolism|March 1, 2017
Optimizing the analysis strategy for the CANVAS Program: A prespecified plan for the integrated analyses of the CANVAS and CANVAS-R trialsBruce Neal, Vlado Perkovic, Kenneth W Mahaffey, et al.
Pageof 12

Showing results (81-90 of 115) with videos related to

Sort By:
Pageof 12
Diabetes/Metabolism Research and Reviews|September 24, 2004
Severe hypoglycaemia in 1076 adult patients with type 1 diabetes: influence of risk markers and selectionUlrik Pedersen-Bjergaard, Stig Pramming, Simon R Heller, et al.
Diabetologia|January 14, 2015
Management of hyperglycaemia in type 2 diabetes, 2015: a patient-centred approach. Update to a position statement of the American Diabetes Association and the European Association for the Study of DiabetesSilvio E Inzucchi, Richard M Bergenstal, John B Buse, et al.
Diabetes Care|April 21, 2012
Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)Silvio E Inzucchi, Richard M Bergenstal, John B Buse, et al.
Circulation|March 19, 2019
Effects of Canagliflozin on Heart Failure Outcomes Associated With Preserved and Reduced Ejection Fraction in Type 2 Diabetes MellitusGemma A Figtree, Karin Rådholm, Terrance D Barrett, et al.
Diabetes Care|December 25, 2014
Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American Diabetes Association and the European Association for the Study of DiabetesSilvio E Inzucchi, Richard M Bergenstal, John B Buse, et al.
Plos One|April 16, 2015
Successful up-scaled population interventions to reduce risk factors for non-communicable disease in adults: results from the International Community Interventions for Health (CIH) Project in China, India and MexicoPamela A Dyson, Denis Anthony, Brenda Fenton, et al.
The Lancet. Diabetes & Endocrinology|June 26, 2018
Canagliflozin and renal outcomes in type 2 diabetes: results from the CANVAS Program randomised clinical trialsVlado Perkovic, Dick de Zeeuw, Kenneth W Mahaffey, et al.
Circulation|November 15, 2017
Canagliflozin for Primary and Secondary Prevention of Cardiovascular Events: Results From the CANVAS Program (Canagliflozin Cardiovascular Assessment Study)Kenneth W Mahaffey, Bruce Neal, Vlado Perkovic, et al.
Diabetes, Obesity & Metabolism|August 17, 2021
Reasons for hospitalizations in patients with type 2 diabetes in the CANVAS programme: A secondary analysisKent Y Feng, JingWei Li, Juliana Ianus, et al.
Diabetes, Obesity & Metabolism|March 1, 2017
Optimizing the analysis strategy for the CANVAS Program: A prespecified plan for the integrated analyses of the CANVAS and CANVAS-R trialsBruce Neal, Vlado Perkovic, Kenneth W Mahaffey, et al.
Pageof 12